Seeking Alpha

Abbott's FreeStyle Libre® Continuous Glucose Monitoring Systems Obtain Significantly Expanded Coverage for Medicare Beneficiaries

"FreeStyle Libre technology was designed from the start to be affordable and accessible," said Jared Watkin, senior vice president for Abbott's diabetes care business. "We've been focused on ...
MobiHealthNews

Abbott's Freestyle Libre system becomes first CGM to be FDA cleared for use without fingersticks

Abbott Diabetes Care's Freestyle Libre Flash Glucose Monitoring System has been approved by the FDA. As well as finally bringing the system, which is already available in 39 other countries, home to ...
FierceBiotech

Abbott's FreeStyle Libre CGM reduces Type 2 diabetes hospitalizations by 67%: study

Abbott’s FreeStyle Libre glucose sensor has already been proven to help people with both Type 1 and Type 2 diabetes better manage their blood sugar levels, and a new study demonstrates just how ...
St. Louis American

Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems

ABBOTT PARK, Ill., June 10, 2024 /PRNewswire/ — Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) clearance for two new over-the-counter continuous glucose monitoring (CGM) ...
Healio

Standalone reader for FreeStyle Libre 3 CGM receives FDA clearance

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA granted clearance for a standalone reader to be ...
KXAN

Abbott Integrates Libre's Data with Epic's Electronic Health Record System, Providing Healthcare Professionals Seamless Glucose Monitoring Information

ABBOTT PARK, Ill., April 29, 2025 /PRNewswire/ -- Abbott (NYSE: ABT), the global leader in continuous glucose monitoring (CGM) biowearable technology 1, today announced that it has entered a ...
Nasdaq

Abbott Says Data Show FreeStyle Libre 3 System Most Accurate 14-Day Continuous Glucose Monitor

(RTTNews) - Abbott (ABT) said late-breaking clinical data showed the FreeStyle Libre 3 system has an overall mean absolute relative difference (MARD) of 7.9%, making it the first and only 14-day ...
Healio

Automated insulin delivery system can now integrate with 15-day CGM sensor

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The Tandem t:slim X2 insulin pump can now integrate with ...

Reasons to Retain Abbott Stock in Your Portfolio Now

ABT's Nutrition rebound and FreeStyle Libre growth fuel momentum, but currency swings and macro pressures could cloud ...
Monthly Prescribing Reference

Abbott’s Modified CGM Sensors Cleared for Integration With AID Systems

The Company is now working with insulin pump manufacturers to integrate their AID systems with the FreeStyle Libre 2 and FreeStyle Libre 3 sensors. The Food and Drug Administration (FDA) has cleared ...
Nasdaq

Abbott (ABT) Receives FDA Nod for FreeStyle Libre 3 System

Abbott Laboratories’ ABT next-generation FreeStyle Libre 3 system was recently approved by the FDA for diabetes patients aged four years and older. The FreeStyle Libre 3 system will be priced ...
Seeking Alpha

Abbott Integrates Libre's Data with Epic's Electronic Health Record System, Providing Healthcare Professionals Seamless Glucose Monitoring Information

Collaboration brings together FreeStyle Libre ® Systems, the world's leading continuous glucose monitoring technology (CGM) 1 with Epic, a healthcare software company, to streamline access to CGM data ...